Last 12 months
Inside the activity.
0 purchase rows · 34 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 166 | $57.28 | $9,508.48 |
DisclosureSEC source: 0001140361-25-005257 · form4.xml · nonDerivative · entry 4 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,916 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-005257 · form4.xml · nonDerivative · entry 3 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest on February 18, 2026. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 1,044 | $57.28 | $59,800.32 |
DisclosureSEC source: 0001140361-25-005257 · form4.xml · nonDerivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,662 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-005257 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2026, and February 17, 2027, respectively. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001140361-25-004765 · form4.xml · derivative · entry 6 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 1,000 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options, representing the right to purchase a total of 15,000 shares, were originally granted on May 4, 2016, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001140361-25-004765 · form4.xml · derivative · entry 5 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017. F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025 Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
SaleCommon Stock | 1,000 | $55.43 | $55,430.00 |
DisclosureSEC source: 0001140361-25-004765 · form4.xml · nonDerivative · entry 4 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,900 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionCommon Stock | 1,000 | $2.76 | $2,760.00 |
DisclosureSEC source: 0001140361-25-004765 · form4.xml · nonDerivative · entry 3 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
SaleCommon Stock | 6,000 | $55.47 | $332,820.00 |
DisclosureSEC source: 0001140361-25-004765 · form4.xml · nonDerivative · entry 2 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,900 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionCommon Stock | 6,000 | $3.74 | $22,440.00 |
DisclosureSEC source: 0001140361-25-004765 · form4.xml · nonDerivative · entry 1 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:05 UTC |
Rubino Alan LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001140361-25-003834 · form4.xml · derivative · entry 4 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017. F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:05 UTC |
Rubino Alan LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001140361-25-003834 · form4.xml · derivative · entry 3 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 4,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015. F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:05 UTC |
Rubino Alan LDirector
|
Exercise / conversionCommon Stock | 15,000 | $3.74 | $56,100.00 |
DisclosureSEC source: 0001140361-25-003834 · form4.xml · nonDerivative · entry 2 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time. Read SEC document |
| February 07, 2025 Filed Feb 11, 2025 21:05 UTC |
Rubino Alan LDirector
|
Exercise / conversionCommon Stock | 4,000 | $3.74 | $14,960.00 |
DisclosureSEC source: 0001140361-25-003834 · form4.xml · nonDerivative · entry 1 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:18 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $13.05 | $0.00 |
DisclosureSEC source: 0001140361-25-003571 · form4.xml · derivative · entry 3 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,500 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018, becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from June 2, 2018 through May 2, 2019. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:18 UTC |
ZERBE ROBERT L MDDirector
|
SaleCommon Stock | 2,500 | $62.50 | $156,250.00 |
DisclosureSEC source: 0001140361-25-003571 · form4.xml · nonDerivative · entry 2 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,595 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:18 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionCommon Stock | 2,500 | $13.05 | $32,625.00 |
DisclosureSEC source: 0001140361-25-003571 · form4.xml · nonDerivative · entry 1 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:12 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,092 | $0.00 Strike: $48.80 | $0.00 |
DisclosureSEC source: 0001140361-25-003567 · form4.xml · derivative · entry 3 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,875 Underlying: Common Stock · 1,092 shares Expires 2031-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 56,875 shares, became exercisable on September 30, 2022, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:12 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
SaleCommon Stock | 1,092 | $61.99 | $67,693.08 |
DisclosureSEC source: 0001140361-25-003567 · form4.xml · nonDerivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,206 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:12 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 1,092 | $48.80 | $53,289.60 |
DisclosureSEC source: 0001140361-25-003567 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:05 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,908 | $0.00 Strike: $48.80 | $0.00 |
DisclosureSEC source: 0001140361-25-002441 · form4.xml · derivative · entry 3 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,967 Underlying: Common Stock · 3,908 shares Expires 2031-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 56,875 shares, became exercisable on September 30, 2022, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:05 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
SaleCommon Stock | 3,908 | $61.99 | $242,256.92 |
DisclosureSEC source: 0001140361-25-002441 · form4.xml · nonDerivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,206 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:05 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 3,908 | $48.80 | $190,710.40 |
DisclosureSEC source: 0001140361-25-002441 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,114 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 31, 2024 Filed Feb 13, 2025 21:05 UTC |
Halpin MichaelChief Operating Officer
|
GrantCommon Stock | 109 | $34.04 | $3,710.36 |
DisclosureSEC source: 0001140361-25-004301 · form5.xml · nonDerivative · entry 3 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,608 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 31, 2024 Filed Feb 13, 2025 21:05 UTC |
Mara Joseph Anthony JrChief Financial Officer
|
GrantCommon Stock | 68 | $34.04 | $2,314.72 |
DisclosureSEC source: 0001140361-25-004299 · form5.xml · nonDerivative · entry 2 Mara Joseph Anthony Jr · CIK 0001841148 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,580 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 31, 2024 Filed Feb 13, 2025 21:05 UTC |
Hopper Jonathan MarkChief Medical Officer
|
GrantCommon Stock | 129 | $34.04 | $4,391.16 |
DisclosureSEC source: 0001140361-25-004298 · form5.xml · nonDerivative · entry 1 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,500 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 21:05 UTC |
Wotton Paul KDirector
|
SaleCommon Stock | 2,600 | $58.72 | $152,672.00 |
DisclosureSEC source: 0001140361-24-048466 · form4.xml · nonDerivative · entry 1 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,402 Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:05 UTC |
Hopper Jonathan MarkChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.66 | $0.00 |
DisclosureSEC source: 0001140361-24-048294 · form4.xml · derivative · entry 3 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 10,000 shares Expires 2029-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 26,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:05 UTC |
Hopper Jonathan MarkChief Medical Officer
|
SaleCommon Stock | 10,000 | $58.72 | $587,200.00 |
DisclosureSEC source: 0001140361-24-048294 · form4.xml · nonDerivative · entry 2 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,371 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 21:05 UTC |
Hopper Jonathan MarkChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $16.66 | $166,600.00 |
DisclosureSEC source: 0001140361-24-048294 · form4.xml · nonDerivative · entry 1 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,371 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 21:05 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $13.05 | $0.00 |
DisclosureSEC source: 0001140361-24-047758 · form4.xml · derivative · entry 3 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 2,500 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018, becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from June 2, 2018 through May 2, 2019. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 21:05 UTC |
ZERBE ROBERT L MDDirector
|
SaleCommon Stock | 2,500 | $60.00 | $150,000.00 |
DisclosureSEC source: 0001140361-24-047758 · form4.xml · nonDerivative · entry 2 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,595 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024. Read SEC document |
| November 22, 2024 Filed Nov 25, 2024 21:05 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionCommon Stock | 2,500 | $13.05 | $32,625.00 |
DisclosureSEC source: 0001140361-24-047758 · form4.xml · nonDerivative · entry 1 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-047069 · form4.xml · derivative · entry 6 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $53.93 | $943,775.00 |
DisclosureSEC source: 0001140361-24-047069 · form4.xml · nonDerivative · entry 4 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,937 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-047069 · form4.xml · nonDerivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001140361-24-047070 · form4.xml · derivative · entry 3 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 7,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017. F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
SaleCommon Stock | 7,000 | $55.54 | $388,780.00 |
DisclosureSEC source: 0001140361-24-047070 · form4.xml · nonDerivative · entry 2 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,900 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionCommon Stock | 7,000 | $3.74 | $26,180.00 |
DisclosureSEC source: 0001140361-24-047070 · form4.xml · nonDerivative · entry 1 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-047069 · form4.xml · derivative · entry 5 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $55.57 | $972,475.00 |
DisclosureSEC source: 0001140361-24-047069 · form4.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,937 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 13, 2024 Filed Nov 15, 2024 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-047069 · form4.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:05 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $13.05 | $0.00 |
DisclosureSEC source: 0001140361-24-046456 · form4.xml · derivative · entry 6 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 2,500 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018, becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from June 2, 2018 through May 2, 2019. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:05 UTC |
ZERBE ROBERT L MDDirector
|
SaleCommon Stock | 2,500 | $57.50 | $143,750.00 |
DisclosureSEC source: 0001140361-24-046456 · form4.xml · nonDerivative · entry 4 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,595 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 21:05 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionCommon Stock | 2,500 | $13.05 | $32,625.00 |
DisclosureSEC source: 0001140361-24-046456 · form4.xml · nonDerivative · entry 3 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:05 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $13.05 | $0.00 |
DisclosureSEC source: 0001140361-24-046456 · form4.xml · derivative · entry 5 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 2,500 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018, becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from June 2, 2018 through May 2, 2019. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:05 UTC |
ZERBE ROBERT L MDDirector
|
SaleCommon Stock | 2,500 | $55.00 | $137,500.00 |
DisclosureSEC source: 0001140361-24-046456 · form4.xml · nonDerivative · entry 2 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,595 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:05 UTC |
ZERBE ROBERT L MDDirector
|
Exercise / conversionCommon Stock | 2,500 | $13.05 | $32,625.00 |
DisclosureSEC source: 0001140361-24-046456 · form4.xml · nonDerivative · entry 1 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 17, 2024 Filed Oct 18, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-043696 · form4.xml · derivative · entry 6 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| October 17, 2024 Filed Oct 18, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $40.34 | $705,950.00 |
DisclosureSEC source: 0001140361-24-043696 · form4.xml · nonDerivative · entry 4 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,937 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.